Cargando…

Relationship between PD-L1 expression and prognostic factors in high-risk cutaneous squamous and basal cell carcinoma

This study aimed to investigate the programmed cell death-ligand 1 (PD-L1) expression in cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC) and its relationship with prognostic factors in tumors that are not in the head and neck region and are therefore relatively less exposed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yülek, Özden, Batur, Şebnem, Özcan, Kerem, Yol, Cansu, Ülgen, Övgü Aydın
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589309/ https://www.ncbi.nlm.nih.gov/pubmed/35801411 http://dx.doi.org/10.17305/bjbms.2022.7574

Ejemplares similares

Programmed Death Ligand 1 Expression in Laryngeal Squamous Cell Carcinomas and Prognosis
por: Batur, Sebnem, et al.
Publicado: (2020)

Facial cutaneous metastasis of rectal adenocarcinoma
por: Samanci, Nilay Sengul, et al.
Publicado: (2020)

Programmed Death-Ligand-1 Expression in Non-Small Cell Lung Cancer and Prognosis
por: Şahin, Songül, et al.
Publicado: (2019)

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
por: Falchook, Gerald S., et al.
Publicado: (2016)

Diagnosis of Lung Adenocarcinoma with Clear Cell Features in Pleural Effusion: Cytomorphologic Features, Immunocytochemical Studies, and Differential Diagnosis
por: Erdogan-Durmus, Senay, et al.
Publicado: (2022)

Diagnostic Value of Preparing Additional Liquid-Based Cytology Slides and Cell Blocks from Residue Material in Thyroid fine Needle Aspiration
por: Erdogan-Durmus, Senay, et al.
Publicado: (2023)

Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
por: Ascierto, Paolo A, et al.
Publicado: (2022)

Immunohistochemical expression of CD10 in cutaneous basal and squamous cell carcinomas
por: Shafaei, Shahriar, et al.
Publicado: (2015)

CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma
por: Nishida, Haruto, et al.
Publicado: (2023)

Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma
por: Clingan, Philip, et al.
Publicado: (2023)

Anti-Inflammatory Effect of Cinnamaldehyde in a Mouse Model of 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis
por: Ustaoglu, Eda, et al.
Publicado: (2023)

Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma
por: Kim, Hae Su, et al.
Publicado: (2016)

Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas
por: Wan, Jun, et al.
Publicado: (2019)

Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck
por: Alaeddini, Mojgan, et al.
Publicado: (2020)

Management of Cutaneous Head and Neck Squamous and Basal Cell Carcinomas for Immunocompromised Patients
por: Bommakanti, Krishna K., et al.
Publicado: (2023)

PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype
por: Kim, Bohyun, et al.
Publicado: (2020)

Concordance of PD-L1 expression and CD8(+) TIL intensity between NSCLC and synchronous brain metastases
por: Batur, Sebnem, et al.
Publicado: (2020)

TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Griewank, Klaus G., et al.
Publicado: (2013)

Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma
por: Korhonen, Niina, et al.
Publicado: (2020)

Value of CD10 Expression in Differentiating Cutaneous Basal from Squamous Cell Carcinomas and Basal Cell Carcinoma from Trichoepithelioma
por: Sari Aslani, Fatemeh, et al.
Publicado: (2013)

Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
por: Weber, Manuel, et al.
Publicado: (2019)

The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression
por: Choi, Jae Won, et al.
Publicado: (2020)

Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis
por: Guo, Wei, et al.
Publicado: (2017)

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
por: Müller, Tim, et al.
Publicado: (2017)

Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2016)

Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus
por: Jackson, S, et al.
Publicado: (2002)

Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford Region.
por: Swerdlow, A. J.
Publicado: (1985)

Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
por: Király, Zsófia, et al.
Publicado: (2022)

Two smoking-related lesions in the same pulmonary lobe of squamous cell carcinoma and pulmonary Langerhans cell histiocytosis: A case report
por: Gencer, Aysegul, et al.
Publicado: (2022)

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
por: Lipson, Evan J., et al.
Publicado: (2017)

Cutaneous metastasis of PD-L1 positive ovarian carcinoma
por: Hastings, Victoria, et al.
Publicado: (2020)

Cutaneous metastasis of PD-L1 positive cervical carcinoma
por: Liu, Chrissy, et al.
Publicado: (2022)

PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma
por: Zeng, Qingyu, et al.
Publicado: (2022)

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
por: Heeren, A Marijne, et al.
Publicado: (2016)

Role of Immunohistochemistry in the Differential Diagnosis of Pediatric Renal Tumors: Expression of Cyclin D1, Beta-Catenin , PDGFR-Alpha, and PTEN
por: Kepil, Nuray, et al.
Publicado: (2022)

Prognostic factors for metastatic cutaneous squamous cell carcinoma of the parotid
por: Makki, Fawaz M, et al.
Publicado: (2013)

PD-1/PD-L1 expression in anal squamous intraepithelial lesions
por: Bucau, Margot, et al.
Publicado: (2020)

Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy
por: Furkert, Chris, et al.
Publicado: (2023)

Cutaneous Basal Cell Carcinoma Arising in Odontogenic Cutaneous Fistula
por: Kim, Nam Gyun, et al.
Publicado: (2017)

TUMOR RECURRENCE FIVE YEARS AFTER TREATMENT OF CUTANEOUS BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA
por: Chren, Mary-Margaret, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jsd4s2vh1iipbgissv6bjdnaq6